By Daniella Parra Recordati said it will acquire the global rights to Enjaymo, used to treat a rare blood disorder, from Sanofi. Enjaymo has been approved by the FDA, European Commission, and Japan’s ...

Recordati SpA (RICFY) reports a 30.5% increase in net revenue and upwardly adjusts its full-year financial targets, showcasing robust performance and strategic progress.

Despite a significant revenue surge, Ligand Pharmaceuticals Inc (LGND) faces leadership transitions and investment ...

Between October and December 2024, 14 listed companies will pay dividends. Interim dividends are also coming. Here's everything you need to know ...